FTC eyes resuming insulin lawsuit against drug middlemen
The U.S. Federal Trade Commission's lawsuit against pharmacy benefit managers over insulin pricing practices will likely move ...
Ferguson Joins, Restarts FTC Case Targeting PBMs Over Insulin Pricing
The FTC's general counsel had stayed the administrative complaint because the two FTC commissioners—Chair Andrew Ferguson and ...
FTC looks to revive insulin lawsuit against pharma middlemen
UnitedHealth (UNH) and Cigna (CI) are under pressure as the FTC looks to resume a lawsuit against their PBMs. Read more here.
Fierce Healthcare23h
FTC pauses lawsuit against PBMs over insulin pricing
The Federal Trade Commission is pressing pause on its legal fight with major pharmacy benefit managers. The agency submitted an order (PDF) this week seeking an administrative stay in the case, as ...
Investing.com India19h
FTC lawsuit against PBMs for insulin pricing to resume
Investing.com -- The lawsuit filed by the U.S. Federal Trade Commission (FTC) against pharmacy benefit managers (PBMs) over insulin pricing practices is set to resume. The case had been temporarily ...
Alabama pharmacist worries about business future
A bill approved by the Alabama Senate sets a $10 drug dispensing fee for pharmacists while also seeking to regulate the ...